Vantage Consulting Group Inc Fibrogen Inc Transaction History
Vantage Consulting Group Inc
- $2.88 Million
- Q1 2025
A detailed history of Vantage Consulting Group Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Vantage Consulting Group Inc holds 195,707 shares of FGEN stock, worth $1.39 Million. This represents 2.09% of its overall portfolio holdings.
Number of Shares
195,707
Previous 195,707
-0.0%
Holding current value
$1.39 Million
Previous $103,000
41.75%
% of portfolio
2.09%
Previous 1.41%
Shares
5 transactions
Others Institutions Holding FGEN
# of Institutions
54Shares Held
33.9MCall Options Held
461KPut Options Held
102K-
Armistice Capital, LLC New York, NY8.5MShares$60.4 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.86MShares$41.7 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA3.74MShares$26.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.41MShares$17.1 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.21MShares$15.7 Million0.0% of portfolio
About FIBROGEN INC
- Ticker FGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,741,200
- Market Cap $666M
- Description
- FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...